ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 46

Secondary Light Chain Editing and Allelic Inclusion in Antibody Secreting Cells from the Minor Salivary Gland

Kristi A. Koelsch1, Kenneth Smith2, Astrid Rasmussen3, C. Erick Kaufman4, David M. Lewis5, Lida Radfar6, Christopher J Lessard2, Biji T Kurien2, Judith A. James3, Kathy L. Sivils3, A. Darise Farris7 and R. Hal Scofield8, 1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Okalahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Medicine, University of Oklahoam Health Sciences Center, Oklahoma City, OK, 5Department of Oral Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 7Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 8Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: antibodies and tolerance, B cells, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: B Cell Biology and Targets in Autoimmune Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Heavy and light chain gene usage and mutational analyses of the Ig variable regions (V-regions) enable the identification of gene usage within B cell populations. Within the context of antibody secreting cells (ASC) isolated from the minor salivary glands of Sjogren’s syndrome (SS) patients it may give clues to the loss of tolerance that leads to the genesis of autoreactive cells described in these patients.

Methods:

Fourteen subjects were included in this study. Each had symptomatic dry eyes and mouth; 8 subjects met American/European Consensus Group (AECG) primary SS criteria and 1 subject also met the American College of Rheumatology criteria for SLE. Six subjects that did not meet the SS classification criteria (DNMC) served as sicca controls. Labial salivary glands were collected, ASCs were isolated and single-cell sorted using a new method that allows for probing of both kappa and lambda light chains within in the same single cells in rare populations. Cells were sequenced and analyzed for V-region gene usage.

Results:

We identified a total of 83 unique heavy/light chain pairs from the SS patient group and 21 from the DNMC control group. No significant differences in the VH- or JH- gene-family usage were noted between SS or DNMC. The Ig VH family usage in both the SS patient and DNMC control groups was dominated by the VH3 and VH4 gene families and JH4 was the predominant JH gene family used by both groups. The light chain analysis revealed that kappa variable region (Vκ) gene families, Vκ1 and Vκ3, were the most frequently used in both groups. The kappa joining (Jκ) gene analysis revealed that J-genes, Jκ-1 through Jκ-5, were represented in sequences from both groups. The light chain sequence analyses also revealed the incidence of secondary light chain editing in the sequences from 2 pSS subjects and one DNMC, indicated by clonally related heavy chains with different light chain usage. These light chain sequences were unique and not found in any of the other pairs utilized by any of the other subjects. In addition, allelic inclusion, or 1 heavy chain with 2 distinct light chains within the same cell, was identified in 2 instances from the ASCs isolated from one pSS patient. In each case, both a kappa and a lambda light chain sequence were amplified from the same cell.

Conclusion:

In summary, we have developed an improved method for the isolation, characterization and mAb production for rare B cells populations, which has provided data suggesting ASC light chain editing and allelic inclusion not previously reported in SS.


Disclosure: K. A. Koelsch, None; K. Smith, None; A. Rasmussen, None; C. E. Kaufman, None; D. M. Lewis, None; L. Radfar, None; C. J. Lessard, None; B. T. Kurien, None; J. A. James, None; K. L. Sivils, None; A. D. Farris, None; R. H. Scofield, None.

To cite this abstract in AMA style:

Koelsch KA, Smith K, Rasmussen A, Kaufman CE, Lewis DM, Radfar L, Lessard CJ, Kurien BT, James JA, Sivils KL, Farris AD, Scofield RH. Secondary Light Chain Editing and Allelic Inclusion in Antibody Secreting Cells from the Minor Salivary Gland [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/secondary-light-chain-editing-and-allelic-inclusion-in-antibody-secreting-cells-from-the-minor-salivary-gland/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/secondary-light-chain-editing-and-allelic-inclusion-in-antibody-secreting-cells-from-the-minor-salivary-gland/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology